Panado maker Adcock Ingram lifts earnings and dividend by double-digits

Drug maker Adcock Ingram has reported a double-digit increase in full-year earnings and dividends even as the seller of brands such as Corenza C and Panado navigated a weak economy that saw consumers coming under increasing pressure.

It described its results as a"healthy financial and operational performance" amid a weak economy characterised by currency weakness and volatility. It also noted that SA's cash-strapped consumers had also been constrained during the period.

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen